AIL
HAE icon

AGF Investments LLC’s Haemonetics HAE Stock Holding History

AGF Investments LLC’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-82
Closed -$10K – 668
2019
Q2 		$10K Sell
82
-16
-16% -$1.57K ﹤0.01% 509
2019
Q1 		$9K Sell
98
-1,646
-94% -$150K ﹤0.01% 508
2018
Q4 		$174K Buy
1,744
+1,000
+134% +$105K 0.02% 281
2018
Q3 		$87K Sell
744
-292
-28% -$30.2K 0.01% 286
2018
Q2 		$94 Buy
1,036
+405
+64% +$34.2K 0.01% 303
2018
Q1 		$49K Sell
631
-17
-3% -$1.17K 0.01% 296
2017
Q4 		$40K Buy
+648
New +$34.1K 0.01% 258

Other funds holding HAE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

AGF Investments LLC's HAE Position: Q3 2019 in Review

AGF Investments LLC sold out of Haemonetics (HAE) in Q3 2019, closing a stake of 82 shares — an estimated $10K sold.

AGF Investments LLC first reported a position in HAE in Q4 2017 and held it in 7 quarters. The position peaked at $174K in Q4 2018. 275 funds tracked by Wall St. Rank hold HAE as of Q3 2019.

  • AGF Investments LLC reported no remaining Haemonetics position as of Q3 2019 after selling out during the quarter.
  • AGF Investments LLC sold 82 Haemonetics shares in Q3 2019, an estimated $10K.
  • AGF Investments LLC first reported a position in Haemonetics in Q4 2017 and held it in 7 quarters.
  • AGF Investments LLC's Haemonetics position peaked at $174K in Q4 2018.
  • 275 funds tracked by Wall St. Rank held Haemonetics as of Q3 2019.

Based on AGF Investments LLC's 13F filing for Q3 2019, filed 12 Nov 2019.